Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robin, E.
Right arrow Articles by Burke, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Robin, E.
Right arrow Articles by Burke, C.

Chest, Vol 89, 576-578, Copyright © 1986 by American College of Chest Physicians

ARTICLES

The recrudescent epidemic of retrolental fibroplasia

ED Robin and CM Burke

We are probably observing a recrudescent epidemic of RLF which has elicited surprisingly little attention from the medical community. Given present data, it is not unreasonable to conclude that there is a true epidemic and that its etiologic basis involves a population of infants with high susceptibility to oxygen toxicity whose oxygen status is being monitored by methods which are not sufficiently accurate to provide the necessary narrow limits of permissible O2 administration. A clinical trial which looked at the outcome of premature infants with and without transcutaneous O2 monitoring would be useful not only to determine the impact on the prevalence of RLF, but also to determine the role of this technology in the management of premature infants generally.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American College of Chest Physicians.